Owing to differences in Cx43 expression and behaviors that are typical of aggressive glioma, we sought to compare the secretomes of C6/C6-13 cells by quantitative proteomics (nanoHPLC-MS/MS). This evidence concerns the gene GJA1 and central nervous system cancer.